QIAGEN NV : Gets a Neutral rating from UBS -February 07, 2024 at 08:29 am EST
Initially Neutral on the company, UBS's analyst John Sourbeer maintained his recommendation.
Stay updated with breaking news from Initially Neutral. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Initially Neutral on the company, UBS's analyst John Sourbeer maintained his recommendation.
Initially Neutral on the company, JP Morgan's analyst Sandeep Deshpande maintained his recommendation. The target price is lowered from CHF 10.50 to CHF 2.75.
Initially Neutral on the company, JP Morgan's analyst Raul Sinha maintained his recommendation. The target price remains unchanged at EUR 5.
Initially Neutral on the company, Deutsche Bank's analyst Nicolai Kempf maintained his recommendation. The target price has been revised upwards and is now set at EUR 17, compared with EUR 15...
Initially Neutral on the company, RBC's analyst Wassachon Udomsilpa maintained his recommendation.